Gene: ADAMTS2
Official Full Name: ADAM metallopeptidase with thrombospondin type 1 motif 2provided by HGNC
Gene Summary: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01638 | ADAMTS2 Knockout cell line (HeLa) | Human | ADAMTS2 | 1:3~1:6 | Negative | Online Inquiry |
KO01639 | ADAMTS2 Knockout cell line (HEK293) | Human | ADAMTS2 | 1:3~1:6 | Negative | Online Inquiry |
ADAMTS2 Gene Knockout Cell Lines are specialized cellular models designed to elucidate the functional roles of the ADAMTS2 gene, which encodes an enzyme involved in the cleavage of collagen and other extracellular matrix components. By employing targeted gene knockout technology, these cell lines enable researchers to create a controlled environment where the effects of the absence of ADAMTS2 can be studied in depth. The mechanism of action is based on the deliberate inactivation of the gene, allowing for the assessment of various downstream biological processes, including cell signaling, migration, and tissue remodeling, which are critical in understanding diseases such as fibrosis and certain cancers.
The scientific importance of ADAMTS2 Gene Knockout Cell Lines is underscored by their diverse applications in both basic and translational research. In clinical settings, these models can facilitate the study of extracellular matrix dynamics and their implications in disease progression, ultimately aiding in the development of targeted therapies. Their use in drug discovery and testing can accelerate the identification of potential therapeutic agents that modulate ECM interactions, thus addressing structural anomalies associated with various pathologies.
Compared to standard cell lines, which may carry functional ADAMTS2, these knockout models provide a unique advantage by offering exceptionally clear insights into the gene’s specific influences. This specificity allows for more precise experimental outcomes, reducing ambiguities often observed when utilizing unmodified lines or alternative gene-editing strategies.
For researchers and clinicians, the ability to manipulate genetic factors accurately is invaluable, contributing to advancements in personalized medicine and targeted treatments. Our company is committed to delivering high-quality biological products, and our expertise in gene editing technologies ensures that ADAMTS2 Gene Knockout Cell Lines can stand up to rigorous scientific scrutiny, making them an essential tool for advancing research in cell biology and pathology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.